Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 3866

BillFederalHouseIn Committee
Maternal and Infant Syphilis Prevention Act
About This Bill
Committee
Latest Action · June 10, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Congress
119th (2025–2027)
Introduced
June 10, 2025
Cosponsors (4)
3D 1R
View PDF ↗

Summary

Highlight any text to annotate
This bill directs the Secretary of Health and Human Services to develop federal guidance on best practices for screening and treating syphilis in pregnant women and infants covered by Medicaid and the Children's Health Insurance Program (CHIP). The legislation responds to a sharp rise in syphilis cases—reaching the highest number since 1950 with over 3,800 cases of congenital syphilis in 2023—which can cause serious health problems including miscarriage, stillbirth, and lifelong disabilities in newborns. The guidance must address strategies such as expanding syphilis screening for pregnant women, particularly during the third trimester and at delivery, improving provider and patient education, integrating telehealth services, and enhancing treatment access. The Secretary must issue this guidance within 12 months of the bill's enactment and submit a progress report to Congress within 2 years. The guidance will also apply to Indian Health Service programs and tribal organizations, ensuring recommendations reach underserved populations.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.